Skip to main content
Enterprise AI Analysis: End-to-End Pipeline for Automated Heart Failure Diagnosis with Clinical Notes using SNOMED-CT

MEDICAL DATA ANALYSIS

End-to-End Pipeline for Automated Heart Failure Diagnosis

Leveraging AI and SNOMED-CT with German clinical notes for enhanced diagnostic accuracy.

Unlocking Clinical Insights: Key Impact Metrics

Our pipeline revolutionizes heart failure diagnosis by significantly improving accuracy and efficiency through advanced NLP and standardized medical terminologies.

0% Abbreviation Disambiguation Accuracy
0% Entity Linking F1-score (ShARe/CLEF)
0% Heart Failure Classification F1-score

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Abbreviation Disambiguation
Entity Linking
Heart Failure Classification

The pipeline addresses semantic ambiguity in clinical notes by performing context-based abbreviation disambiguation. This zero-shot learning approach eliminates the need for extensive manually curated training datasets, improving scalability and generalizability.

Our method achieved a remarkable 96.1% total accuracy on the CASI dataset, outperforming existing state-of-the-art methods. On the challenging WSRS Clinical Abbreviation dataset, it yielded a total accuracy of 64.5%. This high performance for languages lacking training data is a significant step forward.

The entity linking component standardizes medical information by linking clinical entities to SNOMED-CT or UMLS concepts. This ensures high-quality, unambiguous data for downstream applications like heart failure prediction.

On the ShARe/CLEF 2014 dataset, our pipeline achieved an F1-score of 78.8%, a 2.2% increase with prior abbreviation disambiguation. For MedMentions, the F1-score was 46.8%. An expert survey on the German DARIO dataset showed 74% correctly linked entities, highlighting its real-world applicability despite low inter-rater agreement for some categories.

The final step classifies patients into four heart failure groups: No HF, HFrEF, HFmrEF, and HFpEF. This leverages both SNOMED-CT concepts extracted from clinical notes and structured EHR data.

The SVM classifier, combining EHR and SNOMED-CT data, achieved an F1-score of 65.3%, matching the fine-tuned medBERT.de neural baseline. This represents an 8.2% improvement over using EHR data alone and 1.6% over using only SNOMED-CT concepts, demonstrating the power of multimodal data integration. Highest accuracy was observed for 'No HF' (86.0%) and HFrEF (68.4%).

Enterprise Process Flow

Abbreviation Disambiguation
Translation (German to English)
Entity Linking (SNOMED-CT)
Heart Failure Classification

Enhanced Diagnostic F1-Score

65.3% Achieved with combined EHR and SNOMED-CT data

Classifier Performance Comparison

Classifier Trained With Precision in % Recall in % F1 in %
Patient information from EHR (SVM) 58.6 57.4 57.1
SNOMED-CT concepts from entity links (SVM) 63.6 65.0 63.7
Patient information from EHR + SNOMED-CT concepts from entity links (SVM) 64.9 66.4 65.3
Clinical notes (fine-tuned medBERT.de) 64.9 64.3 63.8
Clinical notes + Patient information from EHR (late fusion with fine-tuned medBERT.de) 66.2 65.2 65.3

Real-World Impact: DARIO Dataset

The DARIO dataset, comprising 846 German patients, served as a crucial real-world clinical use case. Our pipeline's ability to process German clinical notes, translate them, and link to SNOMED-CT, demonstrates its practical utility for diverse healthcare settings.

74% of linked entities were correctly identified by cardiologists, validating the pipeline's real-world accuracy.

ROI Calculator: Streamline Clinical Workflows

Estimate potential annual savings and reclaimed hours by integrating our AI-driven diagnostic pipeline into your enterprise's clinical operations.

Estimated Annual Savings $0
Hours Reclaimed Annually 0

Implementation Roadmap

A phased approach to integrate our AI pipeline into your clinical decision support systems, ensuring seamless transition and maximized impact.

Phase 1: Pilot & Customization

Initial setup, data integration, and fine-tuning of the pipeline with a subset of your clinical data. Establish baselines and demonstrate proof-of-concept.

Phase 2: Scaled Deployment & Training

Full integration across relevant clinical departments, user training, and continuous feedback loops for iterative improvements.

Phase 3: Advanced Integration & Expansion

Explore integration with other systems (e.g., EHR), expand to other disease areas, and leverage online learning for sustained performance gains.

Ready to Transform Your Diagnostic Capabilities?

Book a free consultation with our AI specialists to explore how this end-to-end pipeline can be tailored to your organization's specific needs and drive better patient outcomes.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking